Venom May Become a New Painkiller for Terminally Ill Patients
WARRENSVILLE HEIGHTS, Ohio, May 8, 1996 -- Meridia Center for
Rehabilitation and Pain Management at Meridia South Pointe Hospital is pleased to announce
its participation in a new clinical study to treat terminally ill cancer and AIDS patients
with chronic pain. These are patients who have demonstrated a non-response or intolerance
to opiate therapy.
Meridia South Pointe Hospital is one of 30 sites in the
United States who are participating in the study sponsored by Neurex
Corporation in Menlo Park, California, and Medtronic, Inc., in Minneapolis, MN.
Medicine often fails to offer relief to patients with chronic pain.
Medicines such as aspirin are far too weak and narcotics such as morphine often work for a
while, but patients quickly become physically dependent and require ever stronger doses.
More than a decade ago Baldomero Olivera and
his colleagues at the University of Philippines in Manila
observed that several varieties of the cone snail had evolved a sting potent enough to
completely paralyze a fish within seconds. Cone snails, which live in the oceans, all use
chemical weapons -- a mixture of neurotoxins injected through a harpoonlike tube tipped
with a barbed tooth -- to catch their prey.
Since then researchers have isolated one class
of peptides from the cone snail venom that may ease human suffering by interrupting
pain signals as they travel through the spinal cord to the brain. As a consequence, pain
is blocked without numbness. This potential analgesic is called
SNX-111 . It is chemically synthesized based on the composition of the venom from cone
In this large-scale controlled trial of SNX-111, the drug is delivered through an implantable pump . The refillable pumps, which are made by Medtronic and are regularly used to deliver narcotics, can administer small quantities of the drug directly to the spinal cord in a chronic manner.
For updates refer to original source: Doctor's Guide to the Internet
Do you have any positive comments or/and questions ? Please send to Dr. Bruce Livett
Copyright © 1998 Dynamix@WORK! All rights reserved. Last updated on December 17, 2003.